134 related articles for article (PubMed ID: 19419474)
1. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
[TBL] [Abstract][Full Text] [Related]
2. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Ho NT; Lansang P; Pope E
J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
[TBL] [Abstract][Full Text] [Related]
3. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
[TBL] [Abstract][Full Text] [Related]
4. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
[TBL] [Abstract][Full Text] [Related]
6. Ulcerated infantile hemangioma treated with imiquimod.
Mascarenhas R; Guiote V; Agro J; Henrique M
Dermatol Online J; 2011 Sep; 17(9):13. PubMed ID: 21971278
[TBL] [Abstract][Full Text] [Related]
7. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
9. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
[TBL] [Abstract][Full Text] [Related]
10. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
Hu L; Huang HZ; Li X; Lin XX; Li W
Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
[TBL] [Abstract][Full Text] [Related]
11. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
Quirk C; Gebauer K; Owens M; Stampone P
Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
Célestin Schartz NE; Chevret S; Paz C; Kerob D; Verola O; Morel P; Lebbé C
J Am Acad Dermatol; 2008 Apr; 58(4):585-91. PubMed ID: 18068265
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
Senchak AJ; Dann M; Cable B; Bessinger G
Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
15. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of molluscum contagiosum in children.
Myhre PE; Levy ML; Eichenfield LF; Kolb VB; Fielder SL; Meng TC
Pediatr Dermatol; 2008; 25(1):88-95. PubMed ID: 18304162
[TBL] [Abstract][Full Text] [Related]
17. Involution of infantile haemangiomas after imiquimod 5% cream.
Barry RB; Hughes BR; Cook LJ
Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
[TBL] [Abstract][Full Text] [Related]
18. Propranolol reduces infantile hemangioma volume and vessel density.
Bingham MM; Saltzman B; Vo NJ; Perkins JA
Otolaryngol Head Neck Surg; 2012 Aug; 147(2):338-44. PubMed ID: 22691693
[TBL] [Abstract][Full Text] [Related]
19. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety.
Mao XH; Wang JY; Yan JL
J Zhejiang Univ Sci B; 2012 Sep; 13(9):745-50. PubMed ID: 22949365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]